|Last Price||Today's Change||52-Week Range||Trading Volume|
|1.80||-0.06 (-3.23%)||1.65 - 7.77||2.6 million (Below Avg)|
Market data as of 4:00PM 04/17/14. Quotes are delayed by at least 15 min.
These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
|Performed well consistently?||Fail|
|Avoids excess debt?||Fail|
|Converting sales to profits?||Fail|
|Shareholder's money handled rationally?||Neutral|
|Increased shareholder value?||Neutral|
|Consistently increased owner earnings?||Fail|
|Sells at 25% discount to intrinsic value?||Fail|
These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
|Pays a cash dividend?||Neutral|
|Room to increase dividends?||Fail|
|Increased earnings over time?||Neutral|
|Borrows within reasonable limits?||Fail|
|Stock is undervalued?||Fail|
|Have investors caught on?||Fail|
|Has support of institutional investors?||Fail|
|Has sufficient liquidity?||Pass|
Lieff Cabraser Reminds Galena Biopharma, Inc. Investors of Upcoming Deadline in Class Action Litigation – GALE
Business Wire - Friday 04/11/2014 6:28 PM ET
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Galena Biopharma, Inc. and Certain Officers - GALE
PR Newswire - Friday 04/11/2014 4:14 PM ET
GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against GALENA BIOPHARMA, INC. and Its Board and a Lead Plaintiff Deadline of May 5, 2014 -- GALE
Business Wire - Thursday 04/10/2014 12:15 PM ET
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Galena Biopharma, Inc. to Contact Brower Piven Before the May 5, 2014 Lead Plaintiff Deadline
Business Wire - Wednesday 04/09/2014 5:14 PM ET
INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Galena Biopharma, Inc.
Business Wire - Thursday 04/03/2014 1:03 PM ET
Morning Analysis on Top Gainers -- Research on Teva Pharmaceutical Industries, Capstone Turbine, Cigna, and Galena Biopharma
PR Newswire - Tuesday 04/01/2014 9:29 AM ET
Hagens Berman Reminds Galena Biopharma, Inc. Investors of May 5, 2014, Lead Plaintiff Deadline and Continued Securities Fraud Investigation
Business Wire - Monday 03/31/2014 1:37 PM ET
Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Galena Biopharma, Inc.
Business Wire - Friday 03/28/2014 9:49 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|